
ROSALIND ADVISORS, INC.
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | IDYA | 350K | $9.52M |
![]() | CGON | 300K | $12.08M |
![]() | QURE | 125K | $7.30M |
![]() | TRVI | 100K | $915.00K |
![]() | VRNA | 100K | $10.67M |
![]() | KURA | 100K | $885.00K |

IDEAYA Biosciences, Inc.
IDYA
Shares Held
350K
Value
$9.52M

CG Oncology, Inc. Common stock
CGON
Shares Held
300K
Value
$12.08M

uniQure N.V.
QURE
Shares Held
125K
Value
$7.30M

Trevi Therapeutics, Inc.
TRVI
Shares Held
100K
Value
$915.00K

Verona Pharma plc
VRNA
Shares Held
100K
Value
$10.67M

Kura Oncology, Inc.
KURA
Shares Held
100K
Value
$885.00K
